Generating good evidence for new cancer treatments is seriously tough.
By Professor Liam Bourke, Sheffield Hallam University There are lots of reasons for this. The subject matter is complex. Capturing and recording prospective data in […]
Articles by Jane Rigney
Computer says “no”
By Robert Music, Chief Executive, Jo’s Cervical Cancer Trust Of the five million women invited every year for cervical screening in the UK, over one […]
Rates of cervical cancer in women aged 20-24 in England seen to double – should we be worried?
The HPV virus causes most cases of cervical cancer. This is why an HPV vaccination programme for girls aged 12 to 13 started in 2008. […]
Doug Altman – A Giant Among Statisticians
I’m sure there will be many obituaries over the coming days, and if you want a synopsis of Professor Altman’s accomplishments you can read his […]
Data protection versus health protection
On 25th of May 2018 the EU General Data Protection Regulation (GDPR) went live. GDPR is designed to protect EU citizens from organisations using their data […]
To tell or not to tell – what should we do?
The clinical director of the Irish national cervical screening programme Ireland, Dr Grainne Flannelly, resigned at the end of April. It was revealed that she […]
Is it safe to export cancer screening?
A woman in the Republic of Ireland, Vicky Phelan, recently settled with a laboratory in America receiving $2.5million compensation for them missing abnormalities on her […]
The breast screening scandal: Part 1 – why did it happen?
The Secretary of State for Health, Jeremy Hunt, announced in the House of Commons that 450,00 women missed out on breast cancer screening invitations due to an […]
The breast screening scandal: Part 2 – should women accept catch-up invitations?
A group of doctors and health experts wrote to The Times urging women aged 70-79 who did not undergo routine breast cancer screening because of […]